Intensity Therapeutics Inc (INTS) current stock price is $0.33. During the last trading session, the stock soared, reaching $5.0 after opening at $0.34. The stock’s lowest point was $1.5 before it closed at $0.33.
Intensity Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $5.09 on 07/15/24, and the lowest price during the same period was recorded at $0.26 on 06/27/25.
52-week price history of INTS Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Intensity Therapeutics Inc’s current trading price is -93.46% away from its 52-week high, while its distance from the 52-week low is 27.94%. The stock’s price range for this period has remained between $0.26 and $5.09. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.4 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.86 million over the last three months.
Financial Performance and Market Capitalization
Intensity Therapeutics Inc (INTS) has experienced a quarterly decline of -82.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.68M and boasts a workforce of 16 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1667, with a change in price of -1.6798. Similarly, Intensity Therapeutics Inc recorded 1,185,657 in trading volume during the last 100 days, posting a change of -82.75%.
INTS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INTS stands at 0.39. Similarly, the long-term debt-to-equity ratio is also 0.30.
INTS Stock Stochastic Average
As of today, the raw stochastic average of Intensity Therapeutics Inc over the past 50 days is 21.44%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 81.23%. Additionally, the Stochastic %K and %D values for the company were 55.18% and 32.64%, respectively, over the past 20 days.
INTS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -93.21%. However, over the last six months, the performance has been stronger by -83.19%. The price of INTS decreased -42.50% over the last 30 days. And in the last five days, it has surged by 17.47%.
